Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Conley
B A
BA
Gore-Langton
R E
RE
Cheson
B D
BD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000556:secondary / Q000628:therapy*; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D017671:Platinum Compounds / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D012008:Recurrence
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D007211:Indoles; D017671:Platinum Compounds; D011758:Pyrroles; C116890:Semaxinib; D000068818:Cetuximab